Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position among OTC-listed companies through consistent financial growth, timely reporting, vertical integration, prudent capital allocation, and ownership of hard real estate assets. Revenue increased to $35.7 million in FY2026 from $33.1 million in FY2025 and $11.95 million in FY2024, while gross profit rose to $25.5 million from $24.3 million and $7.8 million. The company attributes this progress to strategic investments and acquisitions made without adding debt, particularly its purchase of Avenvi, a real estate company whose 13-property portfolio includes the Texas property housing ETST’s Mister Meds pharmacy. Avenvi also provides financial services and manages real estate development and investment activities, giving ETST an additional asset-based component that complements its healthcare, pharmacy, and telemedicine operations.
To view the full article, visit https://nnw.fm/VUv4f
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://nnw.fm/ETST
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer